Gemfrac Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Teriparatide (600mcg)
Overview Gemfrac Injection
Parathyroid hormone therapy, specifically Gemfrac Injection, is a synthetic treatment for severe osteoporosis in men and postmenopausal women at elevated fracture risk. This medication promotes bone growth, leading to increased bone density and reduced spinal fracture probability. Administration involves subcutaneous injection, either self-administered or by a medical professional, maintaining a consistent daily schedule for optimal results. Treatment typically lasts up to two years, although the physician's guidance should be followed for the full course, regardless of perceived improvement. Refrigerated storage (2-8°C) is essential. Common side effects may include arthralgia, local injection site inflammation (pain, edema, erythema), and lower extremity spasms. Report persistent or bothersome side effects to your doctor. Prior to commencing therapy, disclose any kidney disease history, including nephrolithiasis, as hypercalcemia may occur. Pregnant or lactating individuals should seek medical counsel before use. Treatment efficacy may be monitored via bone densitometry.
Uses of Gemfrac Injection
Bone fragility
Major Benefits of Gemfrac Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gemfrac Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Gemfrac Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemfrac Injection works:
Gemfrac Injection, a manufactured analog of the naturally occurring parathyroid hormone (PTH), stimulates bone-building cells (osteoblasts), enhancing bone density and reducing fracture vulnerability.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Gemfrac Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Gemfrac Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Gemfrac Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administering Gemfrac Injection may induce drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should receive Gemfrac Injection only with careful monitoring. The Gemfrac Injection dosage might require modification. Physician consultation is advised. Gemfrac Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemfrac Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemfrac Injection :
Should you forget a Gemfrac Injection dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gemfrac Injection
| Label | Value |
|---|---|
| Type of Compound | Synthetic Parathyroid Hormone Preparations |
| Addictive | None. |
| Medication Classification | ENDOCRINE REGULATORS |
3,018 People bought this recently